Argenx
Netherlands-based Argenx Raises $1.1 Billion in Global Offering Following Success in Clinical Trials
2023-07-23
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19